Free Writing Prospectus Dated June 18, 2024 Filed Pursuant to Rule 433(d) Registration No. 333-260819 Registration No. 333-260819-11 |
CarMax Select Receivables Trust (CMXS 2024-A) Non-prime Auto Loan *PRICING DETAILS*
Joint Lead Bookrunners: Wells Fargo (str), Barclays, and J.P. Morgan
Co-Managers: MUFG, RBC Capital Markets, and SMBC Nikko
-CAPITAL STRUCTURE-
CLS | SIZE ($MM) | WAL* | S&P/F | P.WIN* | E.FINAL* | L.FINAL | BENCH | SPRD | YLD% | CPN% | $PX | |||||||||||
============================================================================================================ | ||||||||||||||||||||||
A-1 | 110.000 | 0.19 | A-1+/F1+ | 01-05 | 11/2024 | 07/2025 | I-CRV | 25 | 5.617 | 5.617 | 100.00000 | |||||||||||
A-2A | 153.310 | 0.92 | AAA/AAA | 05-20 | 02/2026 | 09/2027 | I-CRV | 73 | 5.852 | 5.780 | 99.99858 | |||||||||||
A-2B | 80.000 | 0.92 | AAA/AAA | 05-20 | 02/2026 | 09/2027 | SOFR30A | 73 | 100.00000 | |||||||||||||
A-3 | 130.020 | 2.12 | AAA/AAA | 20-32 | 02/2027 | 11/2028 | I-CRV | 80 | 5.462 | 5.400 | 99.99851 | |||||||||||
B | 46.670 | 2.86 | AA/AA | 32-38 | 08/2027 | 01/2030 | I-CRV | 95 | 5.416 | 5.350 | 99.98465 | |||||||||||
C | 49.330 | 3.38 | A/A | 38-45 | 03/2028 | 01/2030 | I-CRV | 130 | 5.693 | 5.620 | 99.97987 | |||||||||||
D | 55.670 | 3.72 | BBB/BBB | 45 | 03/2028 | 12/2030 | I-CRV | 200 | 6.359 | 6.270 | 99.97928 | |||||||||||
============================================================================================================ |
* Pricing Speed: 1.50 ABS to 10% Clean-Up Call.
-TRANSACTION DETAILS-
Offered Size : $625,000,000 *No Grow*
Format : SEC Registered
ERISA Eligible : Yes
Expected Settlement: 6/26/2024
First Payment Date : 7/15/2024
Expected Ratings : S&P / Fitch
Min Denoms : $5k x $1k
Bloomberg Ticker : CMXS 2024-A
Bill & Deliver : Wells Fargo
-MARKETING MATERIALS-
Preliminary Prospectus, FWP: Attached
Intex Dealname: wscarmax2024_a | Password: UJBB
DealRoadshow: https://dealroadshow.com
Entry Code (Case Sensitive): CMXS2024A
Direct Link: https://dealroadshow.com/e/CMXS2024A
If this communication relates to an offering of US registered securities (i) a registration statement has been filed with the SEC, (ii) before investing you should read the filed documents, and (iii) you may obtain these documents from your sales representative, by calling 1-800-645-3751 or visiting www.sec.gov. If this communication relates to a securities offering exempt from US registration, you should contact your sales representative for the complete disclosure package.